Isis Pharmaceuticals, Inc.
(NASDAQ:ISIS)|
14.10 -0.76 (-5.11%) Jan 07 - Close |
|
|
|
After-Hours 14.11 +0.01 (0.07%) Wed, 7 Jan 2009 7:40 PM
- Compare ISIS with:
- View: Line | Candlestick
Company Profile
Isis Pharmaceuticals, Inc.
1896 Rutherford Rd
Carlsbad, CA 92008
United States - Map
Phone: (760) 931-9200
Fax: (760) 603-2700
Website: www.isispharm.com
State of incorporation: Delaware
CEO: Dr. Stanley T. Crooke, M.D., Ph.D.
Employees: 300
Sector: Healthcare
Industry Group: Drugs
Industry: Drug Manufacturers - Other
Dev new drugs called antisense oligonucleotides
The Company is in the business of antisense technology exploiting a novel drug discovery platform to create a pipeline of first-in-class drugs.
Recent news for ISIS
-
Cramer's Lightning Round - Cleaning Up with American Ecology (1/6/09)
Seeking Alpha - 19 hours ago
-
Lightning Round: Wells Fargo, Goodyear, Waste Management and More
CNBC - Yesterday at 9:18 ET
-
CNBC - Yesterday at 8:02 ET
-
CNBC - Yesterday at 6:40 ET
-
Isis closes Ibis sale to Abbott for $175 million
AP - Yesterday at 10:36 ET
-
Abbott Completes Acquisition of Ibis Biosciences, a Subsidiary of Isis
PR Newswire - Yesterday at 9:30 ET
-
Zacks.com - Jan 05 at 1:00 ET
-
Isis with Potential Blockbusters
Zacks.com - Jan 02 at 3:00 ET
-
A Post-Holiday Breakup ... of Sorts
Motley Fool - Dec 30 2008 at 2:16 ET
-
5 Stocks Approaching Greatness
Motley Fool - Dec 23 2008 at 1:31 ET
Member sentiment (?) Neutral
Top members owning ISIS
-
Top 34%
+2.84%
-
Top 40%
+2.20%
-
Top 72%
-0.14%
* Average monthly return vs. S&P 500
Recent opinions on ISIS
-
Top 40 Rated Emerging Bio-Pharma Stocks
Dec 25 2008 at 10:22 ET (By MikeHavRx)